Sign inJoin waitlistJoin the waitlist

Goutham Narla

Internal Medicine

Credentials: · · · ·

History

Mount Sinai Hospital
2008–2011
Internal Medicine
Icahn School of Medicine at Mount Sinai
2006–2008
Medical Genetics and Genomics
Icahn School of Medicine at Mount Sinai
2001–2006
Icahn School of Medicine at Mount Sinai
2002–2006

Research

KLF6, a candidate tumor suppressor gene mutated in prostate cancer
Science · 2001 · First of 13 authors · 389 citations
All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
Review · FEBS Journal · 2016 · Last of 6 authors · 266 citations
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition
Nature Communications · 2014 · 219 citations

Scott Friedman
32 papers
JM
John Martignetti
25 papers
Matthew Galsky
10 papers
Alice Levine
8 papers
SM
Sahar Mazhar
8 papers · 4 as a resident
AK
Alexander Kirschenbaum
6 papers
Danica Wiredja
6 papers · 3 as a resident
Eldad Hod
6 papers · 5 as a resident
DK
David Kastrinsky
5 papers · 1 as a resident
SY
Steven Yea
5 papers · 1 as a resident
MB
Michaela Banck
4 papers
AS
Anthony Scott
3 papers

Grants

Interrogating PP2A to Understand and Treat High-Grade Endometrial Carcinoma
National Cancer Institute · R01
PI · $512.3K · University of Michigan at Ann Arbor
2026–2031
Understanding Tumor Suppressive Functions of Protein Phosphatase 2A
National Cancer Institute · R01
PI · $651K · University of Nebraska Medical Center
2026–2031
Michigan Prostate SPORE 2025-2030
National Cancer Institute · P50
Project lead · $809.6K · University of Michigan at Ann Arbor
2014–2030
Targeting Protein Phosphatase 2A for Takotsubo Syndrome Treatment
National Heart, Lung, and Blood Institute · R01
PI · $1.4M · Emory University
2025–2029